Monday, 4 June 2018

Biosurgery Market is Supposed to Reach US$ 16. Billion By 2025



New York, June 04, 2018: The scope of the report includes a detailed study of global and regional markets on Global Biosurgery Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnson, Sanofi S.A., Stryker Corp., Cryolife Inc., Baxter International Inc., Hemostasis LLC, Atrium Medical Corporation (Maquet Getinge Group), C. R. Bard Inc., Medtronic PLC, Kuros Bioscience, B. Braun Melsungen AG, Covidien PLC. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Biosurgery Market is expected to exceed more than US$ 16.2 Billion by 2025 at a CAGR of 8.3% in the given forecast period.


The Global Biosurgery Market is segmented on the lines of its product type, source, application and regional. Based on product type segmentation it covers adhesion barriers, anti-adhesive agents, hemostatic agents, staple line reinforcement agents, surgical sealants, bone graft subsitutes, soft-tissue attachments (Soft Tissue Patch/Mesh). Based on source segmentation it covers biologics products, synthetics products. Based on application it covers neurological surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, reconstructive surgeries, urology surgeries.

The major driving factors of Global Biosurgery Market are as follows:
  • Increasing availability of multifunctional products
  • Rise in surgeries globally
  • Sports-Related Injuries and Spinal Ailments
  • Developments new launch products and Recent technological developments of biosurgeries
  • Growing aging population
  • Growing investments by the government to enhance the healthcare facilities.
The restraining factors of Global Biosurgery Market are as follows:
  • Expensive biosurgical products and its procedures
  • Improper compensation Scenario for Biosurgery Products
  • Increasing demand for minimally invasive or non-invasive surgeries
  • Strict regulations by various government agencies
  • Lack Skilled Personnel for Effective Use of Biosurgery Products
This report provides:

1) An overview of the global market for Global Biosurgery Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2025.
3) Identifications of new market opportunities and targeted promotional plans for - Global Biosurgery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The Global Biosurgery Market has been segmented as below:
By Product Type Analysis:

·         Adhesion Barriers
·         Anti-adhesive agents
·         Hemostatic Agents
·         Staple Line Reinforcement Agents
·         Surgical Sealants
·         Fibrin Sealants
·         Synthetic Agents/Cyanoacrylates
·         Collagen-Based Sealants
·         Tissue Adhesive Glues
·         Bone Graft Substitutes
·         Bone Allografts
·         Demineralized Bone Matrix (DBM)
·         Synthetic Bone Grafts
·         Bone Morphogenetic Proteins (BMP)
·         Soft-Tissue Attachments (Soft Tissue Patch/Mesh)
·         Synthetic Mesh
·         Biological Mesh
·         Allografts
·         Xenografts

By Source Analysis:
  • Biologics Products
  • Synthetics Products
By Application Analysis:
  • Neurological Surgeries
  • General Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Thoracic Surgeries
  • Gynecology Surgeries
  • Reconstructive Surgeries
  • Urology Surgeries
By Regional Analysis:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Preference for Biological Meshes in Surgical Procedures
           6.2.2 Introduction of New Technologies in the Biosurgery Products Market
           6.2.3 Growth in the Number of Acquisitions in the Biosurgery Products Market
    6.3 Regulatory Analysis
           6.3.1 North America
                    6.3.1.1 U.S.
                    6.3.1.2 Canada
           6.3.2 Europe
           6.3.3 APAC
                    6.3.3.1 Japan
                    6.3.3.2 China
                    6.3.3.3 India
    6.4 Vendor Benchmarking 
7 Biosurgery Products Market, By Type
8 Biosurgery Products Market, By Application
9 Biosurgery Products Market, By Region
10 Competitive Landscape
11 Company Profiles
     11.1 Introduction
     11.2 Baxter International Inc.
     11.3 C.R. Bard, Inc.
     11.4 Covidien PLC (A Subsidiary of Medtronic, Inc.)
     11.5 Johnson & Johnson Services, Inc.
     11.6 Sanofi Group
     11.7 Atrium Medical Corporation (A Part of Getinge Group)
     11.8 B. Braun Melsungen AG
     11.9 Cryolife, Inc.
     11.10 Stryker Corporation
     11.11 Hemostasis, LLC

Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States


Biopsy Devices Market is Determined to Cross US$ 2.50 Billion By 2026



New York, June 04, 2018: The scope of the report includes a detailed study of global and regional markets on Global Biopsy Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The Global Biopsy Devices Market is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers guidance system, needles, guns, reagents and kits, others. Based on application segmentation it covers scientific research, medical diagnostics. Based on end user segmentation it covers hospitals, specialized oncology centers, diagnostic centers, research institutes.
The Global Biopsy Devices Market is expected to exceed more than USD$ 2.70 billion by 2026 at a CAGR of 6.5%.


The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company , Argon Medical Inc., B. Braun Melsungen AG, Boston Scientific Inc., .C. R. Bard, Inc., Hologic, Inc., Cook Medical, INRAD Inc., Devicor Medical Products Inc., PLANMED OY. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The major driving factors of Global Biopsy Devices Market are as follows:
  • Incidence of cancer is on raise
  • Growing demand for minimally invasive biopsy procedure
  • Rapidly aging population
  • Growing public awareness about various disease
  • Early diagnosis and treatment of disease by biopsy devices
  • Advancement in biopsy procedure
 The restraining factors of Global Biopsy Devices Market are as follows:
  • Clinical issues in the core needle biopsy
  • Stringent regulation            
  • Increase complaints regarding the cancer screening procedure
  • High cost of biopsy devices
  • Improper reimbursement policies
This report provides:

1) An overview of the global market for Global Biopsy Devices Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2026.
3) Identifications of new market opportunities and targeted promotional plans for Global Biopsy Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The Global Biopsy Devices Market has been segmented as below:
By Product Analysis:
  • Guidance System
    • Stereotactic X-Ray Guided Biopsy
    • Ultrasound Guided Biopsy
    • MRI Guided Biopsy
  • Needles
    • Core Needle
    • Fine Aspiration Needles
  • Guns
  • Reagents and Kits
  • Others (Brushes, Curettes and Punches etc.)
By Application Analysis:
  • Scientific Research
  • Medical Diagnostics
By End Users Analysis:
  • Hospitals
  • Specialized Oncology Centers
  • Diagnostic Centers
  • Research Institutes
By Regional Analysis:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World


Table of Contents
1 INTRODUCTION
2.  Market Introduction
3.  Global Biopsy Device Analysis Scenario
4.  Market Dynamics
5. Global Biopsy Device Analysis and Forecasts, By Product
6. Global Biopsy Device Analysis and Forecasts, By Application
7. Global Biopsy Device Analysis and Forecasts, By End Users
8. Global Biopsy Device Analysis and Forecasts, By Region
9. North America Biopsy Device Analysis and Forecast
10. Latin America Biopsy Device Analysis and Forecast
11. Western Europe Biopsy Device Analysis and Forecast
12. Eastern Europe Biopsy Device Analysis and Forecast
13. APEJ Biopsy Device Analysis and Forecast
14. Japan Biopsy Device Analysis and Forecast
15. MEA Biopsy Device Analysis and Forecast
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles
16.2.1. Becton, Dickinson and Company
16.2.2. Argon Medical Inc.
16.2.3. B. Braun Melsungen AG
16.2.4. Boston Scientific Inc.
16.2.5. C. R. Bard, Inc.
16.2.6. Hologic, Inc.
16.2.7. Cook Medical
16.2.8. INRAD Inc.
16.2.9. Devicor Medical Products Inc.
16.2.10. PLANMED OY

Media Contact
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States